Related Experiment Videos

Acute myocardial effects of mitoxantrone in the rabbit

Cancer Treatment Reports
|May 1, 1987
PubMed

Insights

Mitoxantrone (DHAD) causes reversible, dose-related cardiac contractility impairment in rabbits, similar to doxorubicin. This animal model aids in studying DHAD

Area of Science:

  • Cardiology
  • Pharmacology
  • Oncology

Background:

  • Clinical studies suggest mitoxantrone (DHAD) may cause cardiotoxicity, similar to anthracyclines.
  • Doxorubicin is known to induce acute cardiac effects, potentially linked to chronic cardiotoxicity.

Purpose of the Study:

  • To investigate if mitoxantrone (DHAD) induces acute cardiac effects in a rabbit model.
  • To compare the acute cardiac effects of DHAD with doxorubicin.

Main Methods:

  • Experiments were conducted on isolated and perfused rabbit hearts.
  • Electrocardiogram (ECG) alterations were assessed in normal rabbits.

Main Results:

  • Mitoxantrone (DHAD) induced a reversible, dose-related impairment of cardiac contractility.
  • No significant ECG alterations were observed in normal rabbits treated with DHAD.

Conclusions:

  • Mitoxantrone (DHAD) exhibits acute cardiac activity in rabbits, similar to doxorubicin.
  • The rabbit heart model is a valuable tool for studying DHAD's cardiac actions and mechanisms.

Related Concept Videos